Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Cellular Immunology|April 12, 2011
Papillomavirus virus like particle-based therapeutic vaccine against human papillomavirus infection related diseases: immunological problems and future directionsJiezhong Chen, Guoying Ni, Xiao Song Liu
Immunology Letters|October 16, 2012
Graphene oxide absorbed anti-IL10R antibodies enhance LPS induced immune responses in vitro and in vivoGuoying Ni, Yuejian Wang, Xiaolian Wu, et al.
Human Vaccines & Immunotherapeutics|September 15, 2015
Combining anaerobic bacterial oncolysis with vaccination that blocks interleukin-10 signaling may achieve better outcomes for late stage cancer managementGuoying Ni, Tianfang Wang, Lin Yang, et al.
Current Oncology Reports|December 31, 2022
PEGylated IL-10: Clinical Development in Cancer Immunotherapy, Where to Go?Bernardo Cavallazzi Sebold, Guoying Ni, Junjie Li, et al.
Human Vaccines & Immunotherapeutics|March 6, 2018
Genital warts treatment: Beyond imiquimodJianwei Yuan, Guoying Ni, Tianfang Wang, et al.
Hellenic Journal of Nuclear Medicine|July 15, 2018
Iodine-125 labeled Australian frog tree host-defense peptides caerin 1.1 and 1.9 better inhibit human breast cancer cells growth than the unlabeled peptides. 125I-caerin 1.9 may better be used for the treatment of breast cancerJianwei Yuan, Xinchao You, Guoying Ni, et al.
Cellular Immunology|November 27, 2015
Blocking IL-10 signalling at the time of immunization renders the tumour more accessible to T cell infiltration in miceShu Chen, Guoying Ni, Xiaolian Wu, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 10, 2023
Going Beyond Host Defence Peptides: Horizons of Chemically Engineered Peptides for Multidrug-Resistant BacteriaBernardo Cavallazzi Sebold, Junjie Li, Guoying Ni, et al.
Plos One|June 7, 2024
Host-defence caerin 1.1 and 1.9 peptides suppress glioblastoma U87 and U118 cell proliferation through the modulation of mitochondrial respiration and induce the downregulation of CHI3L1Yichen Wang, Furong Zhong, Fengyun Xiao, et al.
Journal of Translational Medicine|October 29, 2024
Caerin 1.1 and 1.9 peptides halt B16 melanoma metastatic tumours via expanding cDC1 and reprogramming tumour macrophagesQuanlan Fu, Yuandong Luo, Junjie Li, et al.
Pageof 6